Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- Remitting multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1726-1733

  Van Haren, Keith ^a,b   Tomooka, Beren H ^a,c   Kidd, Brian A ^a   Banwell, Brenda ^d   Bar Or, Amit ^e   Chitnis, Tanuja ^f   Tenembaum, Silvia N ^g   Pohl, Daniela ^h   Rostasy, Kevin ⁱ   Dale, Russell C ^j   O'Connor, Kevin C ^k   Hafler, David A ^k   Steinman, Lawrence ^a   Robinson, William H ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g Hospital de Pediatrfa 'Prof Dr Juan P Garrahan'   (Argentina)

^h CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j UNIVERSITY OF SYDNEY   (Australia)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

acute disseminated encephalomyelitis; autoantibody; autoimmune disease; biomarker; differential diagnosis; immunoassay; immunoglobulin; multiple sclerosis; myelin; Pediatric disease

Indexed keywords

ALPHA B CRYSTALLIN; AUTOANTIBODY; CLAUDIN 11; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MYELIN; MYELIN ASSOCIATED OLIGODENDROCYTE BASIC GLYCOPROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; PREDICTION; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AUTOANTIBODY; AUTOIMMUNE DISEASE; BIOMARKER; DIFFERENTIAL DIAGNOSIS; IMMUNOASSAY; IMMUNOGLOBULIN; MULTIPLE SCLEROSIS; MYELIN; PEDIATRIC DISEASE;

ADOLESCENT; ADULT; ALGORITHMS; ANTIGENS; AUTOANTIBODIES; CHILD; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN PROTEINS; YOUNG ADULT;

EID: 84887551714     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513485653     Document Type: Article

References (39)

1. O'Connor KC, McLaughlin KA, De Jager PL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med. 2007 ; 13: 211-217
2. Lalive PH, Hausler MG, Maurey H, et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler. 2011 ; 17: 297-302
3. Franciotta D, Columba-Cabezas S, Andreoni L, et al. Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol. 2008 ; 200: 125-128
4. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
5. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated encephalomyelitis. Neurology. 2007 ; 68: S23-36
6. Weber MS, Hemmer B, Cepok S. The role of antibodies in multiple sclerosis. Biochim Biophys Acta. 2011 ; 1812: 239-245
7. Wootla B, Denic A, Keegan BM, et al. Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurology Research International. 2011 ;: 14
8. Perini P, Ranzato F, Calabrese M, et al. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2006 ; 77: 953-955
9. Ingram G, Hakobyan S, Robertson NP, et al. Complement in multiple sclerosis: Its role in disease and potential as a biomarker. Clin Exp Immunol. 2009 ; 155: 128-139
10. Horstman LL, Jy W, Ahn YS, et al. Complement in neurobiology. Front Biosci. 2012 ; 17: 2921-2960
11. Robinson WH, DiGennaro C, Hueber W, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med. 2002 ; 8: 295-301
12. Robinson WH, Fontoura P, Lee BJ, et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol. 2003 ; 21: 1033-1039
13. Ousman SS, Tomooka BH, Van Noort JM, et al. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature. 2007 ; 448: 474-479
14. Di Pauli F, Mader S, Rostasy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011 ; 138: 247-254
15. O'Connor KC, Chitnis T, Griffin DE, et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol. 2003 ; 136: 140-148
16. Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008 ; 105: 18889-18894
17. Hedegaard CJ, Chen N, Sellebjerg F, et al. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: A role in regulating cytokine responses to MBP. Immunology. 2009 ; 128: e451-461
18. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
19. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007 ; 68: S7-12
20. Banwell B, Reder AT, Krupp L, et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology. 2006 ; 66: 472-476
21. Kaushansky N, Eisenstein M, Zilkha-Falb R, et al. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev. 2010 ; 9: 233-236
22. Lovato L, Cianti R, Gini B, et al. Transketolase and 2',3'-cyclic- nucleotide 3'-phosphodiesterase type I isoforms are specifically recognized by IgG autoantibodies in multiple sclerosis patients. Mol Cell Proteomics. 2008 ; 7: 2337-2349
23. Bronstein JM, Lallone RL, Seitz RS, et al. A humoral response to oligodendrocyte-specific protein in MS: A potential molecular mimic. Neurology. 1999 ; 53: 154-161
24. Masch A, Zerweck J, Reimer U, et al. Antibody signatures defined by high-content peptide microarray analysis. Methods Mol Biol. 2010 ; 669: 161-172
25. Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002 ; 99: 6567-6572
26. Rauer S, Euler B, Reindl M, et al. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psychiatry. 2006 ; 77: 739-742
27. Quintana FJ, Farez MF, Izquierdo G, et al. Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology. 2012 ; 78: 532-539
28. Mikaeloff Y, Moreau T, Debouverie M, et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr. 2001 ; 139: 443-446
29. Steinman L, Waisman A, Altmann D. Major T-cell responses in multiple sclerosis. Molec Med Today. 1995 ; 1: 79-83
30. Pomes A. Relevant B cell epitopes in allergic disease. Int Arch Allergy Immunol. 2010 ; 152: 1-11
31. Corcoran A, Mahon BP, Doyle S. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1. J Infect Dis. 2004 ; 189: 1873-1880
32. Rothbard JB, Zhao X, Sharpe O, et al. Chaperone activity of alpha B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis. J Immunol. 2011 ; 186: 4263-4268
33. McLaughlin KA, Chitnis T, Newcombe J, et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol. 2009 ; 183: 4067-4076
34. Klawiter EC, Piccio L, Lyons JA, et al. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Arch Neurol. 2010 ; 67: 1102-1108
35. O'Connor KC, Appel H, Bregoli L, et al. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol. 2005 ; 175: 1974-1982
36. Sadaka Y, Verhey LH, Shroff MM, et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol. 2012 ; 72: 211-223
37. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol. 2009 ; 66: 833-842
38. He XL, Radu C, Sidney J, et al. Structural snapshot of aberrant antigen presentation linked to autoimmunity: The immunodominant epitope of MBP complexed with I-Au. Immunity. 2002 ; 17: 83-94
39. Axtell RC, De Jong BA, Boniface K, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010 ; 16: 406-412